-
Symbol
-
IRD on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
5,492,171 shares
-
Security Ownership %
-
8%
Foundation Fighting Blindness Retinal Degeneration Fund ownership in Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)
11 Dec 2025 - Foundation Fighting Blindness Retinal Degeneration Fund has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,492,171 shares of Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD).
This represents 8% ownership of the company.
In their previous filing dated 06 May 2025, Foundation Fighting Blindness Retinal Degeneration Fund had reported owning 9,492,171 shares, indicating a decrease of +42%.
.